Article Text

Download PDFPDF
Guts UK/Dr Falk Pharma UK Awards
  1. Alice Kington
  1. Guts UK Charity, London NW1 4LB, UK
  1. Correspondence to Ms Alice Kington, Guts UK Charity, London NW1 4LB, UK; research{at}gutscharity.org.uk

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

The Guts UK/Dr Falk Pharma 2020 awards are open for applications

The Guts UK/Dr Falk Pharma awards recognise the achievements of those who bring new insight to gastroenterology and hepatology, and the collaboration that furthers patient care. These awards are an opportunity to achieve national recognition as well as the financial support for career progression.

This year’s awards comprise:

A £1000 prize for the best essay on gastroenterology or hepatology research personally undertaken by medical students who were on an intercalated BSc/MRes/MSc/MPH/MBPhD* course during the previous academic year (2018–19).

Four £1500 prizes for medical students taking full-time science degrees (BSc/MRes/MSc/MPH/MBPhD*) focusing on gastrointestinal or liver-related disease in the current academic year (2019–20).

Two £2500 awards for F1/F2 doctors to facilitate prospective research in an area relevant to gastroenterology or hepatology.

A £1000 award for primary and secondary care gastrointestinal/liver nurses for initiatives that have improved patient care. …

View Full Text

Footnotes

  • Contributors Guts UK Charity’s vision is of a world where digestive disorders are better understood, better treated and everyone who lives with one gets the support they need. Guts UK aims to provide expert information, raise public awareness of digestive health and transform the landscape for research into our digestive system to help people affected by diseases of the gut, liver and pancreas.

  • Funding This study was funded by Dr Falk Pharma UK.

  • Competing interests None declared.

  • Patient consent for publication Not required.

  • Provenance and peer review Not commissioned; internally peer reviewed.